Immunology Company Kira Biotech launches with A$20M Series A Funding
Related Articles
-
Dr Silveira presents at The Transplantation Society Conference
On my way to The Transplantation Society (TTS) conference in Spain, I stopped off in Oxford UK, where I...
-
-
2015 – What a Year for DCR!
2015 has been a great year for Dendritic Cell Research. DC Down Under 2015 was another great success. With...
-
Cancer vaccine closer
Featured in Burwood Scene, March 13, 2013. An anti-cancer vaccine is another step closer as the 20-strong team led...
-
Anti-cancer vaccine within reach
Featured in Burwood Scene, August 28, 2012. EXCLUSIVE: A 20-strong team of medical researchers led by Professor Derek Hart...
-
New clinical antibody created using the science of gene cloning
Dendritic Cell Research Publish Landmark Paper Dendritic Cell Research (DCR) has a major interest in Dendritic Cell (DC)...
-
There’s a knack to raising funds
Featured in Burwood Scene, June 18, 2014. WITHOUT exception there will be a story in every Burwood Scene promoting...
-
Dendritic Cell Image for all to see
This is an image of a dendritic cell taken at 100x magnification. Dendritic cells are specialised cells in the...
![](mailto:?subject=Immunology Company Kira Biotech launches with A$20M Series A Funding&body=
<img class="aligncenter wp-image-3224 size-medium" src="http://dcresearch.org.au/wp-content/uploads/2019/10/Kira-Biotech-logo-300x150.jpg" alt="" width="300" height="150" /><br />
Brisbane, 29 October 2019: Kira Biotech today announced it has secured Series A funding of A$20 million to develop therapeutics targeting difficult-to-treat immune system disorders.
The round was led by OneVentures, with significant investment from IP Group and support from the Advance Queensland Business Development Fund. The funds will help advance Kira Biotech’s lead candidate KB312 through phase 1 human studies. <a style="color: #ffcc00;" href="https://kirabiotech.com/wp-content/uploads/2019/10/20191024-Kira-Biotech-Series-A-funding-press-release.pdf">Read More</a>
http://dcresearch.org.au/immunology-company-kira-biotech-launches-with-a20m-series-a-funding/){kind=link}